Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Operating Expenses

VISTAGEN THERAPEUTICS, INC. (VTGN) reported Operating Expenses of $14.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-14

  • VISTAGEN THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $14.82M, a 7.63% decline year-over-year.
  • VISTAGEN THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $17.18M, a 18.66% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $19.85M, a 29.28% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $20.31M, a 40.95% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. operating expenses for fiscal 2026 was $73.39M, a 30.00% increase from fiscal 2025.
  • VISTAGEN THERAPEUTICS, INC. operating expenses for fiscal 2025 was $56.46M, a 65.64% increase from fiscal 2024.
  • VISTAGEN THERAPEUTICS, INC. operating expenses for fiscal 2024 was $34.09M, a 42.27% decline from fiscal 2023.
  • VISTAGEN THERAPEUTICS, INC. operating expenses for fiscal 2023 was $59.04M, a 20.77% increase from fiscal 2022.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filedOperating Expenses 157 monthOperating Expenses 160 monthOperating Expenses 163 monthOperating Expenses 166 monthOperating Expenses 169 monthOperating Expenses 172 monthOperating Expenses 175 monthOperating Expenses 178 monthOperating Expenses 181 monthOperating Expenses 184 month
2026-06-30$14.82M
10-Q · filed 2026-08-14
$32.01M
derived: sum of 2 quarters · filed 2026-08-14
$51.85M
derived: sum of 3 quarters · filed 2026-08-14
$72.17M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$17.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
$37.03M
derived: sum of 2 quarters · filed 2026-06-15
$57.34M
derived: sum of 3 quarters · filed 2026-06-15
$73.39M
10-K · filed 2026-06-15
2025-12-31$19.85M
10-Q · filed 2026-02-12
$40.16M
derived: sum of 2 quarters · filed 2026-02-12
$56.21M
10-Q · filed 2026-02-12
$70.69M
derived: sum of 4 quarters · filed 2026-08-14
2025-09-30$20.31M
10-Q · filed 2025-11-13
$36.36M
10-Q · filed 2025-11-13
$50.84M
derived: sum of 3 quarters · filed 2026-08-14
$66.19M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$16.05M
10-Q · filed 2026-08-14
$30.53M
derived: sum of 2 quarters · filed 2026-08-14
$45.88M
derived: sum of 3 quarters · filed 2026-08-14
$60.29M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$14.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
$29.83M
derived: sum of 2 quarters · filed 2026-06-15
$44.24M
derived: sum of 3 quarters · filed 2026-06-15
$56.46M
10-K · filed 2026-06-15
2024-12-31$15.35M
10-Q · filed 2026-02-12
$29.76M
derived: sum of 2 quarters · filed 2026-02-12
$41.98M
10-Q · filed 2026-02-12
$53.53M
derived: sum of 4 quarters · filed 2026-02-12
2024-09-30$14.41M
10-Q · filed 2025-11-13
$26.63M
10-Q · filed 2025-11-13
$38.18M
derived: sum of 3 quarters · filed 2025-11-13
$46.48M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$12.21M
10-Q · filed 2025-08-07
$23.77M
derived: sum of 2 quarters · filed 2025-08-07
$32.07M
derived: sum of 3 quarters · filed 2025-08-07
$39.12M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$11.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17
$19.85M
derived: sum of 2 quarters · filed 2025-06-17
$26.91M
derived: sum of 3 quarters · filed 2025-06-17
$34.09M
10-K · filed 2025-06-17
2023-12-31$8.29M
10-Q · filed 2025-02-13
$8.30M
10-Q · filed 2024-02-13
$15.35M
derived: sum of 2 quarters · filed 2025-02-13
$22.53M
10-Q · filed 2025-02-13
$22.53M
10-Q · filed 2024-02-13
$34.94M
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30$7.06M
10-Q · filed 2024-11-07
$7.06M
10-Q · filed 2023-11-09
$14.23M
10-Q · filed 2024-11-07
$14.23M
10-Q · filed 2023-11-09
$26.65M
derived: sum of 3 quarters · filed 2024-11-07
$36.59M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$7.17M
10-Q · filed 2024-08-13
$7.18M
10-Q · filed 2023-08-10
$19.59M
derived: sum of 2 quarters · filed 2024-08-13
$29.54M
derived: sum of 3 quarters · filed 2024-08-13
$46.13M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$12.41M
10-K · filed 2023-06-28
$22.36M
derived: sum of 2 quarters · filed 2024-02-13
$38.96M
derived: sum of 3 quarters · filed 2024-02-13
$59.04M
10-K · filed 2024-06-11
$59.04M
10-K · filed 2023-06-28
2022-12-31$9.95M
10-Q · filed 2024-02-13
$26.54M
derived: sum of 2 quarters · filed 2024-02-13
$46.63M
10-Q · filed 2024-02-13
$63.36M
derived: sum of 4 quarters · filed 2024-02-13
2022-09-30$16.60M
10-Q · filed 2023-11-09
$36.68M
10-Q · filed 2023-11-09
$53.41M
derived: sum of 3 quarters · filed 2023-11-09
$64.31M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$20.08M
10-Q · filed 2023-08-10
$36.82M
derived: sum of 2 quarters · filed 2023-08-10
$47.71M
derived: sum of 3 quarters · filed 2023-08-10
$60.87M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$16.73M
10-K · filed 2023-06-28
$27.63M
derived: sum of 2 quarters · filed 2023-06-28
$40.79M
derived: sum of 3 quarters · filed 2023-06-28
$48.89M
10-K · filed 2023-06-28
2021-12-31$10.90M
10-K · filed 2023-06-28
$10.90M
10-Q · filed 2022-02-10
$24.05M
derived: sum of 2 quarters · filed 2023-06-28
$32.16M
10-Q · filed 2023-02-07
$38.82M
derived: sum of 4 quarters · filed 2023-06-28
2021-09-30$13.16M
10-K · filed 2023-06-28
$13.16M
10-Q · filed 2021-11-10
$21.26M
10-Q · filed 2022-11-10
$27.92M
derived: sum of 3 quarters · filed 2023-06-28
$33.53M
derived: sum of 4 quarters · filed 2023-06-28
2021-06-30$8.10M
10-K · filed 2023-06-28
$8.10M
10-Q · filed 2021-08-12
$14.76M
derived: sum of 2 quarters · filed 2023-06-28
$20.37M
derived: sum of 3 quarters · filed 2023-06-28
$24.00M
derived: sum of 4 quarters · filed 2023-06-28
2021-03-31$6.66M
10-K · filed 2021-06-29
$12.27M
derived: sum of 2 quarters · filed 2022-02-10
$15.90M
derived: sum of 3 quarters · filed 2022-02-10
$19.02M
10-K · filed 2022-06-23
2020-12-31$5.61M
10-Q · filed 2022-02-10
$9.24M
derived: sum of 2 quarters · filed 2022-02-10
$12.36M
10-Q · filed 2022-02-10
$15.63M
derived: sum of 4 quarters · filed 2022-02-10
2020-09-30$3.63M
10-Q · filed 2021-11-10
$6.75M
10-Q · filed 2021-11-10
$10.01M
derived: sum of 3 quarters · filed 2021-11-10
$15.98M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$3.12M
10-Q · filed 2021-08-12
$6.38M
derived: sum of 2 quarters · filed 2021-08-12
$12.35M
derived: sum of 3 quarters · filed 2021-08-12
$17.70M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$3.26M
10-K · filed 2021-06-29
$9.23M
derived: sum of 2 quarters · filed 2021-06-29
$14.58M
derived: sum of 3 quarters · filed 2021-06-29
$20.80M
10-K · filed 2021-06-29
2019-12-31$5.96M
10-K · filed 2021-06-29
$5.96M
10-Q · filed 2020-02-13
$11.31M
derived: sum of 2 quarters · filed 2021-06-29
$17.54M
10-Q · filed 2021-02-11
$23.26M
derived: sum of 4 quarters · filed 2021-06-29
2019-09-30$5.35M
10-K · filed 2021-06-29
$5.35M
10-Q · filed 2019-11-07
$11.58M
10-Q · filed 2020-11-12
$17.30M
derived: sum of 3 quarters · filed 2021-06-29
$24.49M
derived: sum of 4 quarters · filed 2021-06-29
2019-06-30$6.22M
10-K · filed 2021-06-29
$11.95M
derived: sum of 2 quarters · filed 2021-06-29
$19.14M
derived: sum of 3 quarters · filed 2021-06-29
$26.57M
derived: sum of 4 quarters · filed 2021-06-29
2019-03-31$5.72M
10-K · filed 2020-06-29
$12.91M
derived: sum of 2 quarters · filed 2020-06-29
$20.35M
derived: sum of 3 quarters · filed 2020-06-29
$24.56M
10-K · filed 2020-06-29
2018-12-31$7.19M
10-K · filed 2020-06-29
$7.19M
10-Q · filed 2019-02-12
$14.62M
derived: sum of 2 quarters · filed 2020-06-29
$18.83M
10-Q · filed 2020-02-13
$22.91M
derived: sum of 4 quarters · filed 2020-06-29
2018-09-30$7.43M
10-K · filed 2020-06-29
$7.43M
10-Q · filed 2018-10-29
$11.64M
10-Q · filed 2019-11-07
$15.72M
derived: sum of 3 quarters · filed 2020-06-29
$18.59M
derived: sum of 4 quarters · filed 2020-06-29
2018-06-30$4.21M
10-K · filed 2020-06-29
$8.29M
derived: sum of 2 quarters · filed 2020-06-29
$11.16M
derived: sum of 3 quarters · filed 2020-06-29
$16.15M
derived: sum of 4 quarters · filed 2020-06-29
2018-03-31$4.08M
10-K · filed 2019-06-25
$6.95M
derived: sum of 2 quarters · filed 2019-06-25
$11.94M
derived: sum of 3 quarters · filed 2019-06-25
$14.20M
10-K · filed 2019-06-25
2017-12-31$2.87M
10-K · filed 2019-06-25
$2.87M
10-Q · filed 2018-02-12
$7.86M
derived: sum of 2 quarters · filed 2019-06-25
$10.12M
10-Q · filed 2019-02-12
$12.67M
derived: sum of 4 quarters · filed 2019-06-25
2017-09-30$4.99M
10-K · filed 2019-06-25
$4.99M
10-Q · filed 2017-11-09
$7.25M
10-Q · filed 2018-10-29
$9.80M
derived: sum of 3 quarters · filed 2019-06-25
$13.69M
derived: sum of 4 quarters · filed 2019-06-25
2017-06-30$2.26M
10-K · filed 2019-06-25
$2.26M
10-Q · filed 2017-08-14
$4.81M
derived: sum of 2 quarters · filed 2019-06-25
$8.70M
derived: sum of 3 quarters · filed 2019-06-25
$11.79M
derived: sum of 4 quarters · filed 2019-06-25
2017-03-31$2.55M
10-K · filed 2018-06-26
$6.43M
derived: sum of 2 quarters · filed 2018-06-26
$9.54M
derived: sum of 3 quarters · filed 2018-06-26
$11.50M
10-K · filed 2018-06-26
2016-12-31$3.89M
10-K · filed 2018-06-26
$3.89M
10-Q · filed 2017-02-13
$6.99M
derived: sum of 2 quarters · filed 2018-06-26
$8.95M
10-Q · filed 2018-02-12
$17.45M
derived: sum of 4 quarters · filed 2018-06-26
2016-09-30$3.10M
10-K · filed 2018-06-26
$3.10M
10-Q · filed 2016-11-14
$5.06M
10-Q · filed 2017-11-09
$13.56M
derived: sum of 3 quarters · filed 2018-06-26
$15.71M
derived: sum of 4 quarters · filed 2018-06-26
2016-06-30$1.96M
10-K · filed 2018-06-26
$1.96M
10-Q · filed 2016-08-12
$10.46M
derived: sum of 2 quarters · filed 2018-06-26
$12.61M
derived: sum of 3 quarters · filed 2018-06-26
$17.99M
derived: sum of 4 quarters · filed 2018-06-26
2016-03-31$8.50M
10-K · filed 2017-06-29
$10.64M
derived: sum of 2 quarters · filed 2017-06-29
$16.03M
derived: sum of 3 quarters · filed 2017-06-29
$17.85M
10-K · filed 2017-06-29
2015-12-31$2.14M
10-K · filed 2017-06-29
$2.14M
10-Q · filed 2016-02-16
$7.53M
derived: sum of 2 quarters · filed 2017-06-29
$9.35M
10-Q · filed 2017-02-13
$12.63M
derived: sum of 4 quarters · filed 2017-06-29
2015-09-30$5.39M
10-K · filed 2017-06-29
$5.39M
10-Q · filed 2015-11-16
$7.21M
10-Q · filed 2016-11-14
$10.48M
derived: sum of 3 quarters · filed 2017-06-29
$11.60M
derived: sum of 4 quarters · filed 2017-06-29
2015-06-30$1.82M
10-K · filed 2017-06-29
$1.82M
10-Q · filed 2015-08-14
$5.10M
derived: sum of 2 quarters · filed 2017-06-29
$6.21M
derived: sum of 3 quarters · filed 2017-06-29
$7.33M
derived: sum of 4 quarters · filed 2017-06-29
2015-03-31$3.28M
10-K · filed 2016-06-24
$4.39M
derived: sum of 2 quarters · filed 2016-06-24
$5.51M
derived: sum of 3 quarters · filed 2016-06-24
$6.78M
10-K · filed 2016-06-24
2014-12-31$1.12M
10-K · filed 2016-06-24
$1.12M
10-Q · filed 2015-02-17
$2.23M
derived: sum of 2 quarters · filed 2016-06-24
$3.50M
10-Q · filed 2016-02-16
$4.57M
derived: sum of 4 quarters · filed 2016-06-24
2014-09-30$1.11M
10-K · filed 2016-06-24
$1.11M
10-Q · filed 2014-11-19
$2.38M
10-Q · filed 2015-11-16
$3.45M
derived: sum of 3 quarters · filed 2016-06-24
$4.90M
derived: sum of 4 quarters · filed 2016-06-24
2014-06-30$1.27M
10-K · filed 2016-06-24
$1.27M
10-Q · filed 2014-08-12
$2.34M
derived: sum of 2 quarters · filed 2016-06-24
$3.79M
derived: sum of 3 quarters · filed 2016-06-24
$5.00M
derived: sum of 4 quarters · filed 2016-06-24
2014-03-31$1.07M
10-K · filed 2015-06-29
$2.51M
derived: sum of 2 quarters · filed 2015-06-29
$3.73M
derived: sum of 3 quarters · filed 2015-06-29
$5.03M
10-K · filed 2015-06-29
$72.79M
10-K · filed 2014-06-25
2013-12-31$1.45M
10-K · filed 2015-06-29
$1.45M
10-Q · filed 2014-02-14
$2.66M
derived: sum of 2 quarters · filed 2015-06-29
$3.96M
10-Q · filed 2015-02-17
$5.43M
derived: sum of 4 quarters · filed 2015-06-29
$71.72M
10-Q · filed 2014-02-14
2013-09-30$1.22M
10-K · filed 2015-06-29
$1.22M
10-Q · filed 2013-11-14
$2.52M
10-Q · filed 2014-11-19
$3.99M
derived: sum of 3 quarters · filed 2015-06-29
$5.91M
derived: sum of 4 quarters · filed 2015-06-29
$70.28M
10-Q · filed 2013-11-14
2013-06-30$1.30M
10-K · filed 2015-06-29
$1.30M
10-Q · filed 2013-08-14
$2.77M
derived: sum of 2 quarters · filed 2015-06-29
$4.69M
derived: sum of 3 quarters · filed 2015-06-29
$6.37M
derived: sum of 4 quarters · filed 2015-06-29
$69.06M
10-Q · filed 2013-08-14
2013-03-31$1.47M
10-K · filed 2014-06-25
$3.39M
derived: sum of 2 quarters · filed 2014-06-25
$5.07M
derived: sum of 3 quarters · filed 2014-06-25
$6.99M
10-K · filed 2014-06-25
$67.76M
10-K · filed 2013-07-18
2012-12-31$1.92M
10-K · filed 2014-06-25
$3.60M
derived: sum of 2 quarters · filed 2014-06-25
$5.52M
10-Q · filed 2014-02-14
$8.78M
derived: sum of 4 quarters · filed 2014-06-25
$66.29M
10-Q · filed 2013-02-14
2012-09-30$1.68M
10-K · filed 2014-06-25
$1.68M
10-Q · filed 2012-11-14
$3.60M
10-Q · filed 2013-11-14
$6.86M
derived: sum of 3 quarters · filed 2014-06-25
$9.71M
derived: sum of 4 quarters · filed 2014-06-25
$64.37M
10-Q · filed 2012-11-14
2012-06-30$1.92M
10-K · filed 2014-06-25
$1.92M
10-Q · filed 2012-08-14
$5.18M
derived: sum of 2 quarters · filed 2014-06-25
$8.03M
derived: sum of 3 quarters · filed 2014-06-25
$10.15M
derived: sum of 4 quarters · filed 2014-06-25
$62.69M
10-Q · filed 2012-08-14
2012-03-31$3.26M
10-K · filed 2013-07-18
$6.11M
derived: sum of 2 quarters · filed 2013-07-18
$8.23M
derived: sum of 3 quarters · filed 2013-07-18
$10.39M
10-K · filed 2013-07-18
$60.77M
10-K · filed 2012-07-02
2011-12-31$2.85M
10-K · filed 2013-07-18
$2.85M
10-Q · filed 2012-02-14
$4.97M
derived: sum of 2 quarters · filed 2013-07-18
$7.13M
10-Q · filed 2013-02-14
$7.13M
10-Q · filed 2012-02-14
$10.20M
derived: sum of 4 quarters · filed 2013-07-18
$57.51M
10-Q · filed 2012-02-14
2011-09-30$2.12M
10-K · filed 2013-07-18
$2.12M
10-Q · filed 2011-11-14
$4.28M
10-Q · filed 2012-11-14
$4.28M
10-Q · filed 2011-11-14
$7.34M
derived: sum of 3 quarters · filed 2013-07-18
$10.46M
derived: sum of 4 quarters · filed 2013-07-18
$54.66M
10-Q · filed 2011-11-14
2011-06-30$2.15M
10-K · filed 2013-07-18
$2.15M
10-Q · filed 2011-08-22
$5.22M
derived: sum of 2 quarters · filed 2013-07-18
$8.33M
derived: sum of 3 quarters · filed 2013-07-18
$9.60M
derived: sum of 4 quarters · filed 2013-07-18
$52.54M
10-Q · filed 2011-08-22
2011-03-31$3.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02
$6.18M
derived: sum of 2 quarters · filed 2012-07-02
$7.44M
derived: sum of 3 quarters · filed 2012-07-02
$8.64M
10-K · filed 2012-07-02
2010-12-31$3.11M
10-Q · filed 2012-02-14
$4.37M
derived: sum of 2 quarters · filed 2012-02-14
$5.57M
10-Q · filed 2012-02-14
2010-09-30$1.26M
10-Q · filed 2011-11-14
$2.46M
10-Q · filed 2011-11-14
2010-06-30$1.19M
10-Q · filed 2011-08-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B